Correction: Interferon β-1a for the treatment of Ebola virus disease: A historically controlled, single-arm proof-of-concept trial.
[This corrects the article DOI: 10.1371/journal.pone.0169255.].
Main Author: | PLOS ONE Staff |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5389843?pdf=render |
Similar Items
-
Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
by: PLOS Medicine Staff
Published: (2016-06-01) -
Interferon β-1a for the treatment of Ebola virus disease: A historically controlled, single-arm proof-of-concept trial.
by: Mandy Kader Konde, et al.
Published: (2017-01-01) -
Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
by: Daouda Sissoko, et al.
Published: (2016-04-01) -
Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
by: Daouda Sissoko, et al.
Published: (2016-03-01) -
Correction: Safety and Efficacy of At-Home Robotic Locomotion Therapy in Individuals with Chronic Incomplete Spinal Cord Injury: A Prospective, Pre-Post Intervention, Proof-of-Concept Study.
by: PLOS ONE Staff
Published: (2015-01-01)